Brain serotonin1A receptor binding measured by positron emission tomography with [11C] WAY-100635: effects of depression and antidepressant treatment PA Sargent, KH Kjaer, CJ Bench, EA Rabiner, C Messa, J Meyer, ... Archives of general psychiatry 57 (2), 174-180, 2000 | 869 | 2000 |
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 DR Owen, AJ Yeo, RN Gunn, K Song, G Wadsworth, A Lewis, C Rhodes, ... Journal of Cerebral Blood Flow & Metabolism 32 (1), 1-5, 2012 | 835 | 2012 |
Fibromyalgia patients show an abnormal dopamine response to pain PB Wood, P Schweinhardt, E Jaeger, A Dagher, H Hakyemez, ... European Journal of Neuroscience 25 (12), 3576-3582, 2007 | 531 | 2007 |
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy AC Tziortzi, GE Searle, S Tzimopoulou, C Salinas, JD Beaver, ... Neuroimage 54 (1), 264-277, 2011 | 458 | 2011 |
Mixed-affinity binding in humans with 18-kDa translocator protein ligands DRJ Owen, RN Gunn, EA Rabiner, I Bennacef, M Fujita, WC Kreisl, ... Journal of nuclear medicine 52 (1), 24-32, 2011 | 431 | 2011 |
The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans A De Silva, V Salem, CJ Long, A Makwana, RD Newbould, EA Rabiner, ... Cell metabolism 14 (5), 700-706, 2011 | 408 | 2011 |
Tremor in Parkinson’s disease and serotonergic dysfunction: An 11C-WAY 100635 PET study M Doder, EA Rabiner, N Turjanski, AJ Lees, DJ Brooks Neurology 60 (4), 601-605, 2003 | 387 | 2003 |
Positron emission tomography molecular imaging for drug development PM Matthews, EA Rabiner, J Passchier, RN Gunn British journal of clinical pharmacology 73 (2), 175-186, 2012 | 372 | 2012 |
Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography AC Tziortzi, SN Haber, GE Searle, C Tsoumpas, CJ Long, P Shotbolt, ... Cerebral cortex 24 (5), 1165-1177, 2014 | 347 | 2014 |
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C] WAY-100635 Z Bhagwagar, EA Rabiner, PA Sargent, PM Grasby, PJ Cowen Molecular psychiatry 9 (4), 386-392, 2004 | 322 | 2004 |
Tracer kinetic modeling of the 5-HT1AReceptor ligand [carbonyl-11C] WAY-100635 for PET RN Gunn, PA Sargent, CJ Bench, EA Rabiner, S Osman, VW Pike, ... Neuroimage 8 (4), 426-440, 1998 | 317 | 1998 |
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans SP David, NV Murthy, EA Rabiner, MR Munafó, EC Johnstone, R Jacob, ... Journal of Neuroscience 25 (10), 2586-2590, 2005 | 312 | 2005 |
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited VJ Cunningham, EA Rabiner, M Slifstein, M Laruelle, RN Gunn Journal of Cerebral Blood Flow & Metabolism 30 (1), 46-50, 2010 | 277 | 2010 |
Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation DR Owen, OW Howell, SP Tang, LA Wells, I Bennacef, M Bergstrom, ... Journal of Cerebral Blood Flow & Metabolism 30 (9), 1608-1618, 2010 | 248 | 2010 |
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study JR Nash, PA Sargent, EA Rabiner, SD Hood, SV Argyropoulos, ... The British Journal of Psychiatry 193 (3), 229-234, 2008 | 227 | 2008 |
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats EC Onwordi, EF Halff, T Whitehurst, A Mansur, MC Cotel, L Wells, ... Nature communications 11 (1), 246, 2020 | 212 | 2020 |
Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans DR Owen, N Narayan, L Wells, L Healy, E Smyth, EA Rabiner, ... Journal of Cerebral Blood Flow & Metabolism 37 (8), 2679-2690, 2017 | 211 | 2017 |
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]‐(+)‐PHNO is a D3 receptor preferring agonist in vivo R Narendran, M Slifstein, O Guillin, Y Hwang, DR Hwang, E Scher, ... Synapse 60 (7), 485-495, 2006 | 195 | 2006 |
Neuroinflammation in treated HIV-positive individuals: a TSPO PET study JH Vera, Q Guo, JH Cole, A Boasso, L Greathead, P Kelleher, EA Rabiner, ... Neurology 86 (15), 1425-1432, 2016 | 180 | 2016 |
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans V Salem, C Izzi‐Engbeaya, C Coello, DB Thomas, ES Chambers, ... Diabetes, Obesity and Metabolism 18 (1), 72-81, 2016 | 176 | 2016 |